Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Watson-Marlow Fluid Technology Group (WMFTG) has expanded its range of peristaltic cased pumps for upstream and downstream bioprocessing tasks. 

Larger Peristaltic Pumps Allow Scale-Up

Sartorius Stedim Biotech has expanded its range of single-use membrane chromatography solutions with Sartobind Cassettes, a pod-like modular system for commercial applications in both capture and polishing.

Single-Use Systems Expand Scale of Chromatography

Horizon to make publicly available its complete annotated CHO cell-line sequence in hopes of driving bioproduction cell-line innovation.


Horizon Discovery Releases CHO Genome Sequence for Bioproduction

FDA advances the progress of biosimilars with acceptance of regulatory filing for biosimilar referencing a blockbuster biologic by Roche.

FDA Accepts Application for Teva’s Herceptin Biosimilar

Agnes Shanley is senior editor of Pharmaceutical Technology.

Eric Jayjock, Patheon’s director of continuous manufacturing, discusses the CDMO’s plans for its new continuous manufacturing business. 

Building a Continuous Processing Culture

Successful development requires coordinating and aligning drug and device design, focusing on a complete drug delivery system that meets patients’ needs.

Taking a Systems Approach to Inhalation Therapy Development

Stainless-steel particulates were found in one lot of 0.9% Sodium Chloride Injection, USP 1000 mL, prompting the recall to the hospital/user level.


ICU Medical Recalls 0.9% Sodium Chloride Injection Due to Particulate Matter

Partnership aims to develop new vaccine regimens against hep B and HIV by combining respective proprietary vaccine technologies.

Janssen, Bavarian Nordic Partner on Hep B and HIV Vaccines

Corning and Gerresheimer have been working together to accelerate innovations for pharmaceutical glass packaging.

Corning and Gerresheimer Collaborate on Valor Glass

The agency has published a Q&A guidance document related to self-identification of facilities, review of generic drug submissions, and inspections.
